Immunology Market Size, Share & Industry Analysis, By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, and Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI100657

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Disease, By Key Region, 2025
2. Key Industry Developments (Mergers, Acquisitions & Partnerships)
3. New Product Launches, Key Players
4. Impact of COVID-19 on Global Immunology Market
Global Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. AbbVie Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Bristol-Myers Squibb Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Eli Lilly and Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. UCB S.A.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. Amgen Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Merck & Co., Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
    7. Novartis AG
  9. Overview
    1. Product
    2. SWOT Analysis
    3. Recent Developments
    4. Strategies
    5. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Disease, By Key Region, 2025
2. Key Industry Developments (Mergers, Acquisitions & Partnerships)
3. New Product Launches, Key Players
4. Impact of COVID-19 on Global Immunology Market
Global Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Immunology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Immunosuppressants
  3. Fusion Proteins
  4. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Rheumatoid Arthritis
  2. Psoriatic Arthritis
  3. Plaque Psoriasis
  4. Ankylosing Spondylitis
  5. Inflammatory Bowel Disease
  6. Prophylaxis of Organ Rejection
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. AbbVie Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Bristol-Myers Squibb Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Eli Lilly and Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. UCB S.A.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. Amgen Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Merck & Co., Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
    7. Novartis AG
  9. Overview
    1. Product
    2. SWOT Analysis
    3. Recent Developments
    4. Strategies
    5. financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Immunology Market Revenue Breakdown (USD billion, %), By Region, 2025 & 2034

Figure 2: Global Immunology Market Value Share (%), By Drug Class, 2025 & 2034

Figure 3: Global Immunology Market Value Share (%), By Disease Indication, 2025 & 2034

Figure 4: Global Immunology Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 5: Global Immunology Market Value (USD billion), By Region, 2025 & 2034

Figure 6: North America Immunology Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 7: North America Immunology Market Value Share (%), By Drug Class, 2025

Figure 8: North America Immunology Market Value (USD billion), By Disease Indication, 2025 & 2034

Figure 9: North America Immunology Market Value Share (%), By Disease Indication, 2025

Figure 10: North America Immunology Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 11: North America Immunology Market Value Share (%), By Distribution Channel, 2025

Figure 12: North America Immunology Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Immunology Market Value Share (%), By Country, 2025

Figure 14: Europe Immunology Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 15: Europe Immunology Market Value Share (%), By Drug Class, 2025

Figure 16: Europe Immunology Market Value (USD billion), By Disease Indication, 2025 & 2034

Figure 17: Europe Immunology Market Value Share (%), By Disease Indication, 2025

Figure 18: Europe Immunology Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 19: Europe Immunology Market Value Share (%), By Distribution Channel, 2025

Figure 20: Europe Immunology Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 21: Europe Immunology Market Value Share (%), By Country/ Sub-Region, 2025

Figure 22: Asia Pacific Immunology Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 23: Asia Pacific Immunology Market Value Share (%), By Drug Class, 2025

Figure 24: Asia Pacific Immunology Market Value (USD billion), By Disease Indication, 2025 & 2034

Figure 25: Asia Pacific Immunology Market Value Share (%), By Disease Indication, 2025

Figure 26: Asia Pacific Immunology Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 27: Asia Pacific Immunology Market Value Share (%), By Distribution Channel, 2025

Figure 28: Asia Pacific Immunology Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 29: Asia Pacific Immunology Market Value Share (%), By Country/ Sub-Region, 2025

Figure 30: Latin America Immunology Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 31: Latin America Immunology Market Value Share (%), By Drug Class, 2025

Figure 32: Latin America Immunology Market Value (USD billion), By Disease Indication, 2025 & 2034

Figure 33: Latin America Immunology Market Value Share (%), By Disease Indication, 2025

Figure 34: Latin America Immunology Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 35: Latin America Immunology Market Value Share (%), By Distribution Channel, 2025

Figure 36: Latin America Immunology Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 37: Latin America Immunology Market Value Share (%), By Country/ Sub-Region, 2025

Figure 38: Middle East & Africa Immunology Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 39: Middle East & Africa Immunology Market Value Share (%), By Drug Class, 2025

Figure 40: Middle East & Africa Immunology Market Value (USD billion), By Disease Indication, 2025 & 2034

Figure 41: Middle East & Africa Immunology Market Value Share (%), By Disease Indication, 2025

Figure 42: Middle East & Africa Immunology Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 43: Middle East & Africa Immunology Market Value Share (%), By Distribution Channel, 2025

Figure 44: Middle East & Africa Immunology Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 45: Middle East & Africa Immunology Market Value Share (%), By Country/ Sub-Region, 2025

Figure 46: Global Immunology Market Share (%), By Company, 2025

List of Tables

Table 1: Global Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 2: Global Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 3: Global Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 4: Global Immunology Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 5: North America Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 6: North America Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 7: North America Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 8: North America Immunology Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 10: Europe Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 11: Europe Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 12: Europe Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13: Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 14: Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 15: Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 16: Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 17: Latin America Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 18: Latin America Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 19: Latin America Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 20: Latin America Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 21: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 22: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2021-2034

Table 23: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 24: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 147

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com